静脉用药调配中心医院感染控制、管理体系的研究
|
摘要
目的探讨静脉用药调配中心有效的医院感染控制、管理体系。方法结合静脉用药调配中心现状,建立静脉用药调配中心医院感染控制、管理体系,应用于我院2017年1～12月的静脉用药调配中心工作中,比较应用前6个月(对照组)和应用后6个月(研究组)收治患者的医院感染发生情况、住院时间、医疗费用。结果研究组患者的医院感染发生率为0.67%,低于对照组患者的4.67%(χ~2=4.623,P <0.05),用药风险事件发生率为0.67%,低于对照组患者的5.33%(χ~2=5.613,P <0.05),住院时间为(5.4±1.2)d,短于对照组患者的(7.1±1.5)d,差异有统计学意义(t=4.010,P <0.05),医疗费用为(0.6±0.3)万元,少于对照组患者的(0.9±0.3)万元,差异有统计学意义(t=4.466,P <0.05)。结论建立符合静脉用药调配中心工作现状的医院感染、管理控制体系,能够有效降低患者的医院感染发生率,有利于减少医疗纠纷的发生。
Objective To explore the effective nosocomial infection control and management system of pharmacy intravenous admixture services. Methods Based on the current situation of pharmacy intravenous admixture services, the nosocomial infection control and management system of pharmacy intravenous admixture services was established. Pharmacy intravenous admixture services was applied in our hospital from January to December 2017. The incidence of nosocomial infection, hospitalization time and hospitalization costs were compared between the 6 months before application(the control group) and the 6 months after application(the study group). Results The incidence of nosocomial infection in the study group was 0.67%, which was lower than that 4.67% in the control group(χ2=4.623, P < 0.05), the incidence of drug risk events was 0.67%, which was lower than that 5.33% in the control group(χ2=5.613, P < 0.05). The hospitalization time of the study group was(5.39±1.22)d, which was shorter than that of the control group(7.11±1.48)d(t=4.010, P < 0.05). The hospitalization costs of the study group was(0.58±0.30) million yuan, which was less than that(0.87±0.25) million yuan of the control group(t=4.466, P < 0.05). Conclusion The establishment of nosocomial infection control and management system of pharmacy intravenous admixture services in line with the current situation can effectively reduce the incidence of nosocomial infection and reduce the incidence of medical disputes.
Objective To explore the effective nosocomial infection control and management system of pharmacy intravenous admixture services. Methods Based on the current situation of pharmacy intravenous admixture services, the nosocomial infection control and management system of pharmacy intravenous admixture services was established. Pharmacy intravenous admixture services was applied in our hospital from January to December 2017. The incidence of nosocomial infection, hospitalization time and hospitalization costs were compared between the 6 months before application(the control group) and the 6 months after application(the study group). Results The incidence of nosocomial infection in the study group was 0.67%, which was lower than that 4.67% in the control group(χ2=4.623, P < 0.05), the incidence of drug risk events was 0.67%, which was lower than that 5.33% in the control group(χ2=5.613, P < 0.05). The hospitalization time of the study group was(5.39±1.22)d, which was shorter than that of the control group(7.11±1.48)d(t=4.010, P < 0.05). The hospitalization costs of the study group was(0.58±0.30) million yuan, which was less than that(0.87±0.25) million yuan of the control group(t=4.466, P < 0.05). Conclusion The establishment of nosocomial infection control and management system of pharmacy intravenous admixture services in line with the current situation can effectively reduce the incidence of nosocomial infection and reduce the incidence of medical disputes.
引文
[1]叶其旺,沈宏伟,梁晓美.静脉用药调配中心加强医院感染管理的方法[J].中医药管理杂志,2015,23(20):87-88.
[2]任卫琼,欧阳荣,刘绍贵.加强医院药品质量管理体系建设,保障临床用药安全有效[J].中国当代医药,2014,21(5):128-130.
[3]吴琴珍,潘月敏,石红荣,等.静脉用药安全管理中的前馈控制[J].中华护理杂志,2014,49(7):824-827.
[4]李震,王明丽,苏莉.静脉用药调配中心医院感染的因素分析[J].中华医院感染学杂志,2014,24(16):4136-4137,4142.
[5]杨艳飞.静脉用药调配中心医院感染管理方法的探讨[J].抗感染药学,2014,11(3):236-238.
[6]范静,高珊珊,乔伟立,等.我院静脉用药调配中心差错分析及防范措施[J].中国药房,2015,1(4):565-567.
[7]张良明,陈彦清,王菲.我院静脉用药调配中心感染控制管理与优化[J].临床医学研究与实践,2016,1(1):115-116.
[8]李健荣,麦健萍,王婷玉.静脉用药调配中心工作人员医院获得性感染的危险因素分析及对策[J].药学服务与研究,2017,17(3):201,217,225.
[9]杨燕,穆殿平,杨又力.静脉用药集中调配中心医院感染管理探讨[J].天津药学,2016,28(4):68-70.
[10]卢春娟,沈国荣,程姣.静脉用药调配中心洁净区的感染及其控制管理[J].抗感染药学,2016,13(4):835-837.
[11]邢孝玲,张璐,崔长然,等.静脉用药调配质量控制的应用评价[J].中华医院感染学杂志,2016,26(15):3593-3594,3600.
[12]王雅蘋,苏素红,戈霓云,等.集束化管理在静脉用药调配中心预防医院感染的应用[J].医院管理论坛,2016,33(4):64-66,68.
[13]方钰.强化管理对静脉用药调配中心医院感染预防效果的探讨[J].中国卫生标准管理,2016,7(6):183-184.
[14]何展旺,李莹,李晖.静脉用药调配中心对肿瘤科不适宜用药干预效果的研究[J].中国医药科学,2017,7(17):47-49.
[15]卢海波,朱龙社,康传哲,等.静脉用药调配中心医院感染控制及管理体系探析[J].西南国防医药,2017,27(12):1377-1379.
[16]俞建平.优化质量管理流程在降低静脉药物配置中心感染的应用[J].中医药管理杂志,2015,23(4):91-93.
[17]高丽.静脉用药调配中心实施绩效管理的探索与实践[J].中国医学创新,2016,13(9):110-113.
[2]任卫琼,欧阳荣,刘绍贵.加强医院药品质量管理体系建设,保障临床用药安全有效[J].中国当代医药,2014,21(5):128-130.
[3]吴琴珍,潘月敏,石红荣,等.静脉用药安全管理中的前馈控制[J].中华护理杂志,2014,49(7):824-827.
[4]李震,王明丽,苏莉.静脉用药调配中心医院感染的因素分析[J].中华医院感染学杂志,2014,24(16):4136-4137,4142.
[5]杨艳飞.静脉用药调配中心医院感染管理方法的探讨[J].抗感染药学,2014,11(3):236-238.
[6]范静,高珊珊,乔伟立,等.我院静脉用药调配中心差错分析及防范措施[J].中国药房,2015,1(4):565-567.
[7]张良明,陈彦清,王菲.我院静脉用药调配中心感染控制管理与优化[J].临床医学研究与实践,2016,1(1):115-116.
[8]李健荣,麦健萍,王婷玉.静脉用药调配中心工作人员医院获得性感染的危险因素分析及对策[J].药学服务与研究,2017,17(3):201,217,225.
[9]杨燕,穆殿平,杨又力.静脉用药集中调配中心医院感染管理探讨[J].天津药学,2016,28(4):68-70.
[10]卢春娟,沈国荣,程姣.静脉用药调配中心洁净区的感染及其控制管理[J].抗感染药学,2016,13(4):835-837.
[11]邢孝玲,张璐,崔长然,等.静脉用药调配质量控制的应用评价[J].中华医院感染学杂志,2016,26(15):3593-3594,3600.
[12]王雅蘋,苏素红,戈霓云,等.集束化管理在静脉用药调配中心预防医院感染的应用[J].医院管理论坛,2016,33(4):64-66,68.
[13]方钰.强化管理对静脉用药调配中心医院感染预防效果的探讨[J].中国卫生标准管理,2016,7(6):183-184.
[14]何展旺,李莹,李晖.静脉用药调配中心对肿瘤科不适宜用药干预效果的研究[J].中国医药科学,2017,7(17):47-49.
[15]卢海波,朱龙社,康传哲,等.静脉用药调配中心医院感染控制及管理体系探析[J].西南国防医药,2017,27(12):1377-1379.
[16]俞建平.优化质量管理流程在降低静脉药物配置中心感染的应用[J].中医药管理杂志,2015,23(4):91-93.
[17]高丽.静脉用药调配中心实施绩效管理的探索与实践[J].中国医学创新,2016,13(9):110-113.